Lower uric acid linked with cognitive dysfunction in the elderly

CNS and Neurological Disorders - Drug Targets

Volumn 14, Issue 5, 2015, Pages 564-566

  Méndez Hernández, Edna ^a,b   Salas Pacheco, José ^a   Ruano Calderón, Luis ^c   Téllez Valencia, Alfredo ^a   Cisneros Martínez, Jorge ^a   Barraza Salas, Marcelo ^a   Arias Carrión, Oscar ^d  

^a UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^b Unidad de Posgrado   (Mexico)

^c Hospital General de Durango   (Mexico)

^d HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

Author keywords

Cardiovascular risk factors; Cognitive dysfunction; Dementia; Elderly; Serum uric acid

Indexed keywords

URIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; HYPOURICEMIA; MALE; MINI MENTAL STATE EXAMINATION; AGING; BLOOD; MENTAL HEALTH; NEUROPSYCHOLOGICAL TEST; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; URIC ACID;

EID: 84930511147     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527314666150430161659     Document Type: Article

References (28)

1. Vieira RT, Caixeta L, Machado S, et al. Epidemiology of early-onset dementia: a review of the literature. Clin Pract Epidemiol Ment Health 2013; 9: 88-95.
2. Mejia-Arango S, Gutierrez LM. Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the Mexican Health and Aging Study. J Aging Health 2011; 23(7): 1050-74.
3. Manrique-Espinoza B, Salinas-Rodriguez A, Moreno-Tamayo K, Tellez-Rojo MM. Functional dependency and falls in elderly living in poverty in Mexico. Salud Publ Mex 2011; 53(1): 26-33.
4. Alvarado-Esquivel C, Hernandez-Alvarado AB, Tapia-Rodriguez RO, Guerrero-Iturbe A, Rodriguez-Corral K, Martinez SE. Prevalence of dementia and Alzheimer's disease in elders of nursing homes and a senior center of Durango City, Mexico. BMC Psychiatry 2004; 4: 3.
5. Irizarry MC, Hyman BT. Alzheimer disease therapeutics. J Neuropathol Exp Neurol 2001; 60(10): 923-8.
6. Chico L, Simoncini C, Lo Gerfo A, et al. Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. Free Radic Res 2013; 47(8): 569-76.
7. Schrag M, Mueller C, Zabel M, et al. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis. Neurobiol Dis 2013; 59: 100-10.
8. Skoumalova A, Hort J. Blood markers of oxidative stress in Alzheimer's disease. J Cell Mol Med 2012; 16(10): 2291-300.
9. Irizarry MC, Raman R, Schwarzschild MA, et al. Plasma urate and progression of mild cognitive impairment. Neurodegener Dis 2009; 6(1-2): 23-8.
10. Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF. Uric acid as a CNS antioxidant. J Alzheimers Dis 2010; 19(4): 1331-6.
11. Spitsin S, Koprowski H. Role of uric acid in Alzheimer's disease. J Alzheimers Dis 2010; 19(4): 1337-8.
12. Weisskopf MG, O'Reilly E, Chen H, Schwarzschild MA, Ascherio A. Plasma urate and risk of Parkinson's disease. Am J Epidemiol 2007; 166(5): 561-7.
13. de Lau LM, Koudstaal PJ, Hofman A, Breteler MM. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol 2005; 58(5): 797-800.
14. Paganoni S, Zhang M, Quiroz Zarate A, et al. Uric acid levels predict survival in men with amyotrophic lateral sclerosis. J Neurol 2012; 259(9): 1923-8.
15. Polidori MC, Mecocci P. Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J Alzheimers Dis 2002; 4(6): 517-22.
16. Rinaldi P, Polidori MC, Metastasio A, et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 2003; 24(7): 915-9.
17. Kim TS, Pae CU, Yoon SJ, et al. Decreased plasma antioxidants in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2006; 21(4): 344-8.
18. Euser SM, Hofman A, Westendorp RG, Breteler MM. Serum uric acid and cognitive function and dementia. Brain 2009; 132(Pt 2): 377-82.
19. Li J, Dong BR, Lin P, Zhang J, Liu GJ. Association of cognitive function with serum uric acid level among Chinese nonagenarians and centenarians. Exp Gerontol 2010; 45(5): 331-5.
20. Schretlen DJ, Inscore AB, Jinnah HA, Rao V, Gordon B, Pearlson GD. Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology 2007; 21(1): 136-40.
21. Afsar B, Elsurer R, Covic A, Johnson RJ, Kanbay M. Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am J Nephrol 2011; 34(1): 49-54.
22. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189-98.
23. Lobo A, Saz P, Marcos G, et al. Revalidation and standardization of the cognition mini-exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population. Med Clin 1999; 112(20): 767-74.
24. Vertesi A, Lever JA, Molloy DW, et al. Standardized Mini-Mental State Examination. Use and interpretation. Can Fam Physician 2001; 47: 2018-23.
25. Molloy DW, Standish TI. A guide to the standardized Mini-Mental State Examination. Int Psychogeriatr 1997; 9 Suppl 1: 87-94.
26. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283(18): 2404-10.
27. Mazza A, Pessina AC, Pavei A, Scarpa R, Tikhonoff V, Casiglia E. Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly. Eur J Epidemiol 2001; 17(12): 1097-104.
28. Sandoval-Rincón M, Sáenz-Farret M, Miguel-Puga A, Micheli F, Arias-Carrión O. Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson’s disease. Front Neurol 2015; 6: 71.